For hospitalized but not critical prostatitis, which regimen is used?

Prepare for the Antibacterials (ABX) Exam. Study with flashcards and multiple-choice questions, each question comes with hints and explanations. Get ready to ace your test!

Multiple Choice

For hospitalized but not critical prostatitis, which regimen is used?

In hospitalized patients with acute bacterial prostatitis who are not critically ill, you want empiric therapy that reliably reaches the prostate and covers the common Gram-negative pathogens, including potential resistant organisms seen in the hospital. A regimen that pairs a fluoroquinolone (which penetrates prostatic tissue well and covers enteric Gram-negatives such as E. coli) with a third-generation cephalosporin (to broaden Gram-negative coverage) provides broad, reliable coverage from the start while cultures are awaited. If you used nitrofurantoin, it wouldn’t reach the prostate adequately. Amoxicillin alone often doesn’t cover the typical pathogens or resistant strains encountered in this setting. Azithromycin isn’t ideal for prostatitis because it lacks reliable activity against the common Gram-negative uropathogens and does not provide the best prostatic penetration or coverage. Thus, the combination of a fluoroquinolone plus a third-generation cephalosporin is the most appropriate empiric regimen for a hospitalized but not critically ill patient with prostatitis.

In hospitalized patients with acute bacterial prostatitis who are not critically ill, you want empiric therapy that reliably reaches the prostate and covers the common Gram-negative pathogens, including potential resistant organisms seen in the hospital. A regimen that pairs a fluoroquinolone (which penetrates prostatic tissue well and covers enteric Gram-negatives such as E. coli) with a third-generation cephalosporin (to broaden Gram-negative coverage) provides broad, reliable coverage from the start while cultures are awaited. If you used nitrofurantoin, it wouldn’t reach the prostate adequately. Amoxicillin alone often doesn’t cover the typical pathogens or resistant strains encountered in this setting. Azithromycin isn’t ideal for prostatitis because it lacks reliable activity against the common Gram-negative uropathogens and does not provide the best prostatic penetration or coverage. Thus, the combination of a fluoroquinolone plus a third-generation cephalosporin is the most appropriate empiric regimen for a hospitalized but not critically ill patient with prostatitis.

More practice questions